Compositions and methods for altering immune function
    1.
    发明授权
    Compositions and methods for altering immune function 有权
    用于改变免疫功能的组合物和方法

    公开(公告)号:US07601355B2

    公开(公告)日:2009-10-13

    申请号:US11444591

    申请日:2006-06-01

    IPC分类号: A61K39/395

    CPC分类号: A61K39/39 A61K2039/55511

    摘要: The present invention relates to molecules that stabilize and/or enhance CD154 activity, compositions comprising these molecules, methods for using these molecules and compositions (e.g., pharmaceutical compositions) comprising them. Specifically, the molecules can be used for enhancing immune function (e.g., enhancing Th1 cytokine expression), stimulating immune responses, and/or treating certain disorders (e.g., cancer, infectious disease, and immune compromised states). The invention also relates to kits and compositions comprising the molecules.

    摘要翻译: 本发明涉及稳定和/或增强CD154活性的分子,包含这些分子的组合物,使用这些分子的方法和包含它们的组合物(例如药物组合物)。 具体地说,该分子可用于增强免疫功能(例如增强Th1细胞因子表达),刺激免疫应答和/或治疗某些疾病(例如癌症,感染性疾病和免疫受损状态)。 本发明还涉及包含该分子的试剂盒和组合物。

    Compositions and methods for altering immune function
    2.
    发明申请
    Compositions and methods for altering immune function 有权
    用于改变免疫功能的组合物和方法

    公开(公告)号:US20070041981A1

    公开(公告)日:2007-02-22

    申请号:US11444591

    申请日:2006-06-01

    IPC分类号: A61K39/395 A61K39/00

    CPC分类号: A61K39/39 A61K2039/55511

    摘要: The present invention relates to molecules that stabilize and/or enhance CD154 activity, compositions comprising these molecules, methods for using these molecules and compositions (e.g., pharmaceutical compositions) comprising them. Specifically, the molecules can be used for enhancing immune function (e.g., enhancing Th1 cytokine expression), stimulating immune responses, and/or treating certain disorders (e.g., cancer, infectious disease, and immune compromised states). The invention also relates to kits and compositions comprising the molecules.

    摘要翻译: 本发明涉及稳定和/或增强CD154活性的分子,包含这些分子的组合物,使用这些分子的方法和包含它们的组合物(例如药物组合物)。 具体地说,该分子可用于增强免疫功能(例如增强Th1细胞因子表达),刺激免疫应答和/或治疗某些疾病(例如癌症,感染性疾病和免疫受损状态)。 本发明还涉及包含该分子的试剂盒和组合物。